Results 161 to 170 of about 334,030 (336)

A DIA‐MS‐based proteomics approach to find potential serum prognostic biomarkers in glioblastoma patients

open access: yesMolecular Oncology, EarlyView.
A DIA‐MS‐based proteomics analysis of serum samples from GB patients and healthy controls showed that high levels of IL1R2 and low levels of CRTAC1 and HRG in serum are associated with poor survival outcomes for GB patients. These circulating proteins could serve as biomarkers for the prediction of outcome in patients with GB.
Anne Clavreul   +11 more
wiley   +1 more source

Wellbeing and Complementary Therapies in Breast Cancer Peripheral Neuropathy Care: A Scoping Review Focused on Foot Health. [PDF]

open access: yesCancers (Basel), 2023
Veiga-Seijo R   +5 more
europepmc   +1 more source

The patient’s motivation in seeking complementary therapies

open access: green, 1999
Paul Ritvo   +5 more
openalex   +2 more sources

EGFR‐STAT3 activation provides a therapeutic rationale for targeting aggressive ETV1‐positive prostate cancer

open access: yesMolecular Oncology, EarlyView.
Cotargeting EGFR and STAT3 with Erlotinib and TTI‐101 impairs both 2D and 3D growth of ETV1‐overexpressing prostate cancer cells by disrupting a self‐sustaining ETV1–EGFR positive feedback loop that promotes EGFR and STAT3 expression and phosphorylation (activation).
Elsa Gomes Paiva   +5 more
wiley   +1 more source

Medicina occidental y otras alternativas: ¿es posible su complementariedad? Reflexiones conceptuales

open access: yesCadernos de Saúde Pública
El presente documento hace parte de una serie de reflexiones sobre el abordaje intercultural de los sistemas de salud y las políticas públicas que le corresponden, provocadas por el estudio de dos hospitales mixtos (interculturales) creados en áreas ...
María Beatriz Duarte Gómez
doaj  

Evaluation and modification of tumor cell isolation techniques from malignant effusions for rapid drug sensitivity testing

open access: yesMolecular Oncology, EarlyView.
Non‐small cell lung cancer targeted treatment is limited to a few known genetic alterations, with few alternatives in advanced treatment lines. To direct treatment decisions by drug sensitivity testing (DST), this study compared several methods for tumor cell isolation from malignant effusions, pointing to repeated CD45+ cell depletion for effective ...
Navit Mooshayef   +10 more
wiley   +1 more source

Complementary therapies in substance use recovery with pregnant women and girls. [PDF]

open access: yesWomens Health (Lond), 2022
Flannigan K   +4 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy